Effects of Yiqi Fuyuan Paste Formula in Chronic Fatigue Syndrome: A Randomized Double-Blind Controlled Clinical Trial.
NCT07320937 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2026-01-06
Summary
The goal of this clinical trial is to learn if "Yiqi Fuyuan Paste Formula" (a traditional Chinese medicinal paste made from medicinal and edible Chinese medicines and health food like Ginseng Radix et Rhizoma, Astragali Radix et Rhizoma, Codonopsis Radix, Atractylodis Macrocephalae Rhizoma, Poria Cocos, Coicis Semen, Dioscoreae Rhizoma, Nelumbinis Semen, Angelicae Sinensis Radix, Lycii Fructus, Citri Reticulatae Pericarpium, Juglandis Semen, Longan Arillus, Sesami Nigri Semen, Jujubae Fructus, Glycyrrhizae Radix et Rhizoma, and fine ingredients) works to ease Chronic Fatigue Syndrome (CFS) symptoms in adults. It will also learn about the safety of "Yiqi Fuyuan Paste Formula". The main questions it aims to answer are:
1. Does "Yiqi Fuyuan Paste Formula" help reduce CFS-related fatigue (measured by the Fatigue Assessment Instrument, FAI)
2. What underlying bodily changes (shown in blood tests) might explain its effects.
Researchers will compare "Yiqi Fuyuan Paste Formula" to a placebo (a look-alike substance that contains no drug) to see if "Yiqi Fuyuan Paste Formula" works to ease CFS symptoms.
Participants will:
1. Take "Yiqi Fuyuan Paste Formula" or a placebo every day for 2 months
2. Visit the clinic before and after the intervention for checkups and tests
3. Keep a diary of their symptoms
Conditions
- CFS
Interventions
- OTHER
-
"Yiqi Fuyuan Paste Formula" test group
The intervention is a custom-made herbal paste prepared from food-medicine homology ingredients, including Astragalus membranaceus, Codonopsis pilosula, Dioscorea opposita, and others. It is administered orally twice daily for 12 weeks to improve immune function and quality of life in patients with chronic fatigue or post-illness recovery. Method of taking the ointment: Start taking it from the time it is prepared. It is generally recommended to take it on an empty stomach. The total duration of taking it is 8 weeks (20g per dose, twice a day), taking it warm in the morning and evening respectively; The ointment should be stored in the refrigerator for refrigeration.
- OTHER
-
Placebo(a look-alike substance that contains no drug)
Method of taking the ointment: Start taking it from the time it is prepared. It is generally recommended to take it on an empty stomach. The total duration of taking it is 8 weeks (20g per dose, twice a day), taking it warm in the morning and evening respectively; The ointment should be stored in the refrigerator for refrigeration.
Sponsors & Collaborators
-
ShuGuang Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-29
- Primary Completion
- 2026-08-18
- Completion
- 2026-11-18
Countries
- China
Study Locations
More Related Trials
-
The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula
NCT06686355 ·Status: RECRUITING ·Phase: PHASE2
-
TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
NCT00540397 ·Status: UNKNOWN ·Phase: NA
-
Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome)
NCT04218487 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis
NCT06933238 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome.
NCT03091634 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)
NCT02875639 ·Status: UNKNOWN ·Phase: PHASE2
-
A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease
NCT06442137 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure
NCT03027375 ·Status: UNKNOWN ·Phase: PHASE2
-
Effectiveness of Yiqi Fumai Lyophilized Injection for Acute Heart Failure
NCT05586048 ·Status: RECRUITING
-
The Effects of Traditional Herbal Dietary Supplements on General Fatigue and Negative Emotions of Graduate Students
NCT05724238 ·Status: UNKNOWN ·Phase: NA
-
Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection
NCT04251871 ·Status: UNKNOWN ·Phase: NA
-
Effect and Safety of TCM-FMD in Phlegm-Dampness Type Overweight/Obesity Patients(EASTAR)
NCT04029571 ·Status: COMPLETED ·Phase: PHASE2
-
A Practical RCT of TCM in the Treatment of LCOVID and Analysis of Syndrome Types and Medication Characteristics.
NCT06095258 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Examining the Function of Cs4 on Post-COVID-19 Disorders
NCT06054438 ·Status: COMPLETED ·Phase: NA
-
Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
NCT05672498 ·Status: UNKNOWN ·Phase: NA
-
China Cimicifuga Trial of Climacteric Complaint Control
NCT00622986 ·Status: UNKNOWN ·Phase: PHASE4
-
TCM for Coal Worker's Pneumoconiosis
NCT04841200 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency
NCT04317339 ·Status: UNKNOWN ·Phase: PHASE2
-
RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy
NCT05229029 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Acupuncture and Chinese Herbal Medicine for Long COVID
NCT07285707 ·Status: RECRUITING ·Phase: NA
-
The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine
NCT01677325 ·Status: COMPLETED ·Phase: PHASE1
-
Chinese Medicine for Patients With LCOVID-19 Symptoms
NCT04924881 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials
NCT03147443 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
NCT01486186 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Study of Alternative Treatments of Unexplained Chronic Fatigue
NCT00983502 ·Status: TERMINATED